non communicable diseases surveillance in india 31 st annual national conference of iapsm,...
TRANSCRIPT
31st Annual National Conference of IAPSM, Chandigarh 27-
29 February 2004 Non Communicable Diseases Non Communicable Diseases
Surveillance in IndiaSurveillance in India
Dr. Bela ShahSr. Deputy Director General
Division of Non-communicable DiseasesIndian Council of Medical Research
New Delhi
Deaths due to Non-communicable and Communicable diseases 1990-2020
India, and World (Males)
5561
6672
3326
2014
41
50.558
66
50
38.530
22
0
10
20
30
40
50
60
70
80
90
1990 2000 2010 2020
Year
World NCD
World CD
India NCD
India CD
ESTIMATED & PROJECTED MORTALITY RATE FOR CAUSES OF DEATH (PER 100,000)
BY SEX, INDIA
1985 2000 2015 M F M F M F
All causes 1158 1165 879 790 846 745 Infectious 478 476 215 239 152 175 Neoplasms 43 51 88 74 108 91 Circulatory 145 126 253 204 295 239 Pregnancy 0 22 0 12 0 10 Perinatal 168 132 60 48 40 30 Injury 85 65 82 28 84 29 Other 239 293 280 285 167 171
(Source : World Bank Health Sectorial Priorities Review)
Mortality by cause in India-1990 & 1998NCDs emerging as major causes of mortality
0
500
1000
1500
2000
2500
3000
1990 1998
Burden of risk factors
Smoking Prevalence by WHO Regions, 1998
Male
Female
World 1998: 1,235,000,000 smokersEstimate 2020: 1,670,000,000 smokers
36.2%
9.4%
34.7%
23.0%
43.8%
23.4%
34.2%
8.7% 48.2%
8.2%
62.3%
5.8%
DALYS (‘000) FOR CARDIOVASCULAR DISEASES IN
INDIA DURING 2000-2020
28500
34929
43524
1593820907
27788
125631402215736
05000
1000015000200002500030000350004000045000
Total Males Females
2000 2010 2020
Source: The Global Burden of Disease by CJL Murray and AD Lopez, WHO 1996
Attributable Mortality & DALYs by Overweight
Mortality (%)
1.1
4.2
9.6
2
5.6
11.5
0
2
4
6
8
10
12
14
HMD LMD Develop
Male Female
DALYs lost(%)
0.6
2.3
6.9
1
3.2
8.1
0
1
2
3
4
5
6
7
8
9
HMD LMD Develop
Male Female
World Health Report 2002
Rising Prevalence of Obesity in Urban India
BMI >27 kg/m2
11.2
22.3
13.2
29.7
0
5
10
15
20
25
30
Male Female
19942001
Gupta et al, IHJ 2002
Surveillance needs for
NCDs
What is surveillance?What is surveillance?
Surveillance is the ongoing collection, analysis, and use of health data for the
planning, implementation, and assessment of disease control
"information for action”
Surveillance needs for NCDs
• Identify extent of the problem
• Map emerging patterns and trends
• Measure progress in primary prevention
• Contribute to policy making
Uses of surveillance dataUses of surveillance data
Surveillance needs for NCDs
Surveillance - essential for health policy
NCD/MH/Injury
Surveillance
Monitoring Evaluation of HP/DP Programmes
Health Information System
Surveillance population measures
Strategy for NCD surveillanceStrategy for NCD surveillance
DiseaseDisease OutcomesOutcomes
Heart disease Stroke
Diabetes Cancer
Respiratory
DiseaseDisease OutcomesOutcomes
Heart disease Stroke
Diabetes Cancer
Respiratory
Physiological RFPhysiological RF BMI Blood pressure Blood glucose Cholesterol
Physiological RFPhysiological RF BMI Blood pressure Blood glucose Cholesterol
Behavioral Behavioral RFRFTobaccoAlcoholPhysical inactivity
Nutrition
Behavioral Behavioral RFRFTobaccoAlcoholPhysical inactivity
Nutrition
The causal chain
… selected risk factors associated with major NCDs and amenable to interventions.
… simple surveillance systems.
… standard definition and methods.
… surveillance for primary prevention of NCDs.
NCD Risk Factor Surveillance: FocusNCD Risk Factor Surveillance: Focus
Rationale for selecting risk factors
Greatest impact on NCD mortality and morbidity;
Modifiable by intervention; Validated measurement; Meaningful comparisons possible; Measurement can be obtained following
ethical standards.
The WHO STEPS approach
Risk factors common to major noncommunicable conditions
ConditionRisk factor
Cardio-vasculardisease*
Diabetes Cancer Respiratoryconditions**
Smoking
Alcohol
Nutrition
Physical inactivity
Obesity
Raised blood pressure
Blood glucose
Blood lipids
SOURCES OF SURVEILLANCE DATA COLLECTION FOR NCDs
in India• Mortality Data
– Medical Certificates for Death– Cause of Death Survey– Hospital Records
• Morbidity data– Registry- Cancer– Special Surveys– Hospital Reports
• Risk Factors– Special Surveys
Current Surveillance Activities
Disease Control Programs• NPSP
• HIV/AIDS
• TB
• Malaria
• Leprosy
NPSCD (National Program for Surveillance of Communicable Diseases)
Other routine Surveillance Activities
NFHS-National Family Health Survey
NSSO-National Sample Survey Organization
Census of India
Ongoing regular periodic surveys
Network of National Cancer Registry Programme
Population Based Cancer Registries
• Mumbai• Bangalore• Chennai• Delhi• Bhopal• Barshi (rural)
Hospital Based Cancer Registries
• Thiruvananthapuram
• Dibrugarh
• Mumbai
• Bangalore
• Chennai
Age-adjusted rate (per 100,000) All cancers, 1997
0 50 100 150 200 250 300 350 400
Bangalore
Bhopal
Chennai
Delhi
Mumbai
Barshi
Connecticut, USA
Oxford, UK
Reg
istr
y
Males Females
Trends in Age standardized Cancer Incidence Rates among Men in India (1982 to 1994)
0
20
40
60
80
100
120
140
160
19821983
19841985
19861987
19881989
19901991
19921993
1994
Age S
tandardized Incidence Rate
Bangalore Mumbai Chennai Delhi Bhopal Barshi
AGE SPECIFIC INCIDENCE , 1997. ALL CANCERS, MALES
0
200
400
600
800
1000
0 10 20 30 40 50 60 70 80AGE-GROUP(YEARS)
INC
IDE
NC
E P
ER
10
0,00
0
BANGALORE BARSHI BHOPAL CHENNAI DELHI MUMBAI
National Cancer Registry Programme1997
Incident Cancer Cases in India
Year Incident Cases
1992 644,600
2001 806,000
Common Cancers among Men in India1997 according to Crude Incidence Rate
Rank Bangalore Bhopal Chennai Delhi Mumbai Barshi
1 Stomach
5.0
Lung
14.5
Stomach
9.6
Lung
7.4
Lung
6.4
Hypophar
3.9
2 Oesophag
4.0
Mouth unspeci
4.7
Lung
8.3
Larynx
5.3
Oesophag
4.3
Oesophag
3.5
3 Lung
3.7
Tongue
4.6
Oesophag
6.7
Prostate
3.6
Larynx
3.7
Liver
3.1
4 Hypophar
3.1
Oesophag
4.5
Tongue
4.3
Brain
3.4
Tongue
3.7
Mye Leuk
2.3
5 Prostate
2.1
Hypophar
3.3
Prostate
4.0
Tongue
3.2
Prostate
3.5
Penis
1.9
Common Cancers among Women in India
Rank Bangalore Bhopal Chennai Delhi Mumbai Barshi
1 Breast
14.8
Cervix 18.7
Cervix
23.6
Breast
19.8
Breast
20.6
Cervix
18.7
2 Cervix
13.8
Breast
12.3
Breast
21.4
Cervix
15.8
Cervix
12.1
Breast
7.5
3 Oesophagus
3.8
Ovary
3.5
Stomach
4.6
Ovary
6.5
Ovary
6.0
Oesopha
2.1
4 Stomach
3.1
Oesophag
2.5
Ovary
4.4
Gall Blad
5.6
Oesophag
3.9
Ovary
2.1
5 Ovary
2.9
Mouth Unspeci
2.5
Oesopha
4.2
Lympho
2.3
Lung
3.0
Gum
1.2
Development of Sentinel Health Monitoring
Centres in India
An ICMR-WHO Initiative
Disease Surveillance
• An Integrated Disease Surveillance System for the country has been a felt need for the country
• It is expected to be the back bone of Public Health System in the country
• Early identification of disease outbreaks & occurrence
• Facilitating resource allocation• Monitoring disease control program
Analyse this Marked Heterogeneity!
Kerala
Delhi
Jammu & Kashmir
Nagaland
Bihar
High literacy rate, developed
Metropolitan city, highly urbanised, heterogeneous population
Nested populationTerrain, relatively underdeveloped
Nested populationUnderdeveloped, Tribes andTerrain
Illiterate, Poor populationRural, Agricultural, Tribals
•Differentdietary patterns
•Differentbody
composition
•Differenthabits
GoalTo develop a sustainable system for NCD Surveillance in India
AimTo set up Regional Sentinel HealthMonitoring Centers for NCDs in India
Following Six centers are carrying out the study, representing 5 Geographic Regions of India
North HaryanaDelhi
CRHSP, BallabhgarhIHBAS, Delhi
South Tamilnadu MDRF, Chennai
East Assam RMRC, Dibrugarh
West Kerela SCTIMS, Thiruvanathapuram
Central Maharashtra GMC, Nagpur
Risk Factors•Tobacco - Current, past, and never. Age of initiation
– Smoking form and nonsmoking form (orally consumed and application forms).
•Alcohol - regular, (age of initiation also) occasional, past, and never. Type of alcohol. Country liquor, IMFL. •Diet- consumption of fruits, vegetables, non-vegetarian food and oil/fat used.•Physical activity- type and degree•Measurements- Blood Pressure, Pulse rate, Waist circumference
Step 3
Comprehensiveness
Co
mp
lexi
ty
Step 2
Step 1Core
Expanded
Optional
The WHO STEPwise approach to Surveillance (STEPS) of NCD Risk
Factors
At each step
The WHO STEPS approach
Levels of Risk Factor Surveillance at each StepMeasures
Level
Step 1
(Verbal)
Step 2
(Physical)
Step 3
(Biochemical)
Core Demographics,Tobacco, Alcohol,
Nutrition,
Physical activity
Measuredweight + height,
Waist girth,
Blood pressure
Cholesterol,
Fasting bloodsugar
Expanded Education,OccupationIndicators,
Hip girth, HDL-Chol,
Triglycerides
Optional Knowledge+attitudes regardinghealth Health-relatedQuality of life andhealth-relatedbehaviour
Skinfolds,Pedometer
Urine, etc.
The WHO STEPS approach
Sample Size
Rural (Male+Female) 3750
Urban (Male+Female) 3750
Total for each Regional Centre 7500
Total for Six Centers(Includes 5000 respondents for IHBAS center)
42500
BEHAVIOURAL RISK FACTORS
“Actions/Behaviour that people engage in that put their health at risk”
NCDs
• Diseases of affluence
• Diseases due to urbanization
• Diseases of developed world
• Chronic diseases
Biobehavioural disorders
HEALTHY WORKPLACESINDIAN EFFORTS
2001-2002 Surveillance of CVD risk factors in 10 major industries across India-
Baseline Survey (in collaboration with CII, MoHFW and WHO)
2003-2004 Development and implementation of health interventions; surveillance of
cause-specific mortality; event registries.
EXTENSIVE BASELINE SURVEY FOR CVD RISK FACTOR AND DETERMINANTS
10 INDUSTRIES TWINNED
WITH MEDICAL COLLEGES
Further surveillance of CVD RF/Determinants for trends
HEALTH EDUCATION AND PROMOTION
COST-EFFECTIVE ALGORITHMS FOR IDENTIFICATION AND PREVENTION OF ACUTE AND CHRONIC CVD
Ascertainment and Monitoring of CVD morbidity and mortality
Study Locations
1. New Delhi
2. Lucknow
3. Ludhiana4. Pune
5. Nagpur
6. Dibrugarh
7. Coimbatore
8. Hyderabad
9. Bangalore
10. Trivandrum
11. Chennai (affiliate center)
Coordinating Center: New Delhi
Study Centers:
Distribution of BMI in Industrial Population Sentinel
Surveillance study
BMI (kg/m2) Male Female
• >23 58.9 63.5
• >25 34.7 43.3
• >27 16.7 26.7
The Concept of IDSP
• Decentralized
• Integrated
• Action oriented
• Bring together both the communicable and non communicable diseases under one surveillance activity.
Background of IDSP
• World Bank funded project through MoH&FW
• Surveillance of infectious and Non- communicable (NCD) diseases share common infrastructure, processes and personnel
• A coordinated approach to data collection, analysis, interpretation and dissemination will facilitate planning and implementation of intervention programs.
DGHS(Co-Chair)
NPO(Cancer, MH)
IMA
NGO
Consultants
Rep.Min Environment NSO
(Member Secretary)
Rep.MOH
DirectorNIB
DirectorNICD
JS(FA)
JS(Welfare)
JS(Health)
DG, ICMR
National Surveillance* Committee
* Chairperson: Secretary Health or Secretary Family Welfare (to alternate)
Organogram National Surveillance Committee
Director HealthServices
State Program Officers
Data ManagerIDSP
Head StatePublic Health
State Trainingofficer
Environment
IMASSO
(Member Secretary)
Min. Home
State coordinator
Medical colleges
NGO
Water board)
DME)
Director (PH)Co-Chair
State Surveillance* Committee
* Chairperson: State Secretary Health
Organogram State Surveillance Committee
Aims of IDSP- NCD risk factor surveillance
1. Monitor trends of important risk factors of NCD in the community over a period of time
2. Evolve strategies for interventions of these risk factors so as to reduce the burden of diseases due to noncommunicable diseases
3. Strengthen NCD surveillance at District level4. To integrate the NCD risk factor surveillance with
IDSP 5. Evolve a data bank
Partners
• Ministry of Health & Family Welfare
• ICMR
• IndiaCLEN
• World Bank
• WHO
• State & District level Surveillance Officers
Research Surveillance Health Policies and programmes
Information
influence
evaluate
Characteristics of a surveillance system
Suggested Strategies for NCD SURVEILLANCE in India
• Integrated national surveillance programme
• Include Comm. Disease and Selected NCDs/ Risk Factors
• Identify populations for development of NCD Risk Factor surveillance module
• Utilize medical schools/ students for implementation
SUGGESTED STRATEGIES for NCD SURVEILLANCE in INDIA
• Initiate National level control programmes
• Establish govt. policies for programme implementation
• Encourage surveillance for NCDs
• Incorporate findings of surveillance into national programmes for Intervention
USERS OF SURVEILLANCE DATA
• Policy Makers & Programme implementors
• Researchers and Public Health specialists
• Collateral agencies- food manufacturers, sports equipment,tobacco industry
• Public, Media
• Associations, Universities
• Donors, private medical services
Key messages
• Recognize the emerging epidemic
• Effective interventions exist
• Partnerships to implement existing knowledge
• Set surveillance systems in place now,
focus on risk factors
• Use a stepwise approach
• Link to policy and planning
Current status of implementation of NCD prevention and control programmes in
SEAR CountriesCountries Tobacco
controlCVD Cancer Diabetes Integrated
control of NCDs
Bangladesh 1982 1978
Bhutan
DPR Korea 2000 2000
India 2000 1975
Indonesia 1989 1995
Maldives 2001
Myanmar 1982 1982 1996 1993
Nepal 1999 1998
Srilanka 1999 2000 2000
Thailand 1988 1988 1988 1988 1993
Note: Shaded areas indicate existence of a plan and the year of implemenation
Source:Non-Communicable Diseases in South-East Asia Region, A Profile, WHO, 2002
Source of NCD related data on the member countries in the region
Mortality Medical Certifictn of DeathIndia MyanmarSri LankaThailand
Cause of death surveysDPR KoreaIndiaIndonesia
Hospital data All countries except Maldives
MorbidityDisease Registries
India (cancer)Indonesia (cancer)Thailand ( injury)Sri Lanka (cancer)
Special SurveysBangladesh DPR Korea IndiaIndonesia MaldivesMyanmar Sri Lanka
Hospital reports All countries except Maldives
Risk Factor DataRegular Surveys
Indonesia
Special Surveys
BangladeshIndiaSri LankaThailand
No information obtainedBhutanDPR KoreaMaldivesMyanmarNepal
Prevention and management of NCDs
• Generating a local information base for action• Establishing a programme for promotion of health
across life span• Tackling issues outside the health sector which
influence prevention and control of NCDs• Ensuring that health sector reforms are responsive
to the challenge